Breaking News on Contract Research, Manufacturing & Clinical Trials

Johnson Matthey posts higher Q3 API profits; Pfizer patent spat continues

28-Jan-2015 - Johnson Matthey saw demand for ADHD APIs increase in the third quarter, while sales of its pain management ingredients and bulk opiates declined.

Catalent to offer integrated services in Germany through softgel expansion

27-Jan-2015 - A coating and packaging expansion at a facility in Germany will feed the demand for end-to-end softgel services, Catalent Pharma Solutions says.

AMRI to make Glide's solid dose injectable candidate from ex-Aptuit site

26-Jan-2015 - AMRI has won a contract to manufacture a solid dose injection (SDI) formulation for Glide Technologies from its newly acquired UK aseptic facility.

News in brief

Neuland Labs passes US FDA audit

26-Jan-2015 - Indian CMO Neuland Labs has passed a US FDA audit at one of its two API plants.

Pharma turning to injectable systems to protect biologics, says Unilife

22-Jan-2015 - Big Pharma firms like AbbVie are partnering with delivery device makers to guard against biosimilar competition according to Unilife CEO,  Alan Shortall.

Lonza benefits from outsourcing growth as Swiss franc fluctuations stall 2015 projections

22-Jan-2015 - Biopharma outsourcing growth has helped to boost the bottom line of Lonza, the world’s largest manufacturer of drug ingredients, though a topsy-turvy Swiss franc has caused the company to hold...

Antitope to produce manufacturing cell lines for two potential HIV vaccines

21-Jan-2015 - Abenza subsidiary Antitope has extended its relationship and will provide manufacturing cell lines for two developing HIV vaccines from the French National Institute of Health and Medical Research (INSERM); the...

AMRI wins 10 year NIH contract to support neurological disease development

20-Jan-2015 - AMRI has won a $38m federal contract to support the National Institutes of Health Drug Manufacturing and Formulation Program (DMFP).

Catalent and Mitsubishi GC team up for Asian cell line offering

20-Jan-2015 - Catalent is taking aim at the Asian market with a partnership with Mitsubishi Gas Chemical Company to make cell lines for the region.

Piramal acquires Kentucky-based CDMO for $30m

20-Jan-2015 - India-based CMO Piramal has acquired US-based sterile injectable CDMO (contract development and manufacturing organization) Coldstream Laboratories for $30.65m.

Cost, not compliance, behind Clayton closure, says Hospira

19-Jan-2015 - Hospira has announced it will close its plant in Clayton, North Carolina that it no longer deems cost effective for drug production.  

Novartis to close Puerto Rico plant and outsource to Eli Lilly

19-Jan-2015 - Novartis will close an OTC plant in Puerto Rico by 2019 and transfer manufacturing and packaging actives to sites in the US and facilities operated by Eli Lilly and Virbac.

Sanofi selects B-I to manufacture growing monoclonal antibody portfolio

16-Jan-2015 - Sanofi has selected Boehringer-Ingelheim to manufacture monoclonal antibodies in an agreement that extends to the French drugmaker's partner Regeneron.

One-stop-shop CMOs could fall into pharma's over-capacity curse, say experts

16-Jan-2015 - CMO consolidation is resurrecting the ‘all-under-one-roof’ manufacturing model, but will firms fall into the same inefficiency pitfalls that drove pharma to outsource in the first place?

Lonza's biopharma focus intensified towards end of 2014

14-Jan-2015 - Lonza signed a flurry of biopharma-related deals and launched a number of drug industry services in the final quarter of 2014 as its efforts to focus on pharma intensified.

AMRI looks to replace Allegra royalty revenue with contract revenue

14-Jan-2015 - 2015 is the year that AMRI loses its royalties for discovering the API of Allegra and the company is now looking to its string of recent acquisitions and new contract...

News in brief

AMRI to develop and manufacture parenteral generics for Genovi

13-Jan-2015 - AMRI has won a contract to develop and manufacture five parenteral generic products for Genovi Pharmaceuticals.

Micronization getting bigger: Fareva invests in capacity citing increasing demand

13-Jan-2015 - Fareva has added extra micronization capacity citing growing demand and the opportunity to work with customers earlier in the development process as the driver for the investment.

AMRI acquiring Aptuit assets, including UK aseptic site, in $60m deal

09-Jan-2015 - AMRI has paid $60m for two Aptuit facilities including an aseptic manufacturing site in Glasgow, UK which the firm says will boost its presence in Europe.

US FDA lifts import alert at Hospira device plant in Costa Rica

09-Jan-2015 - Hospira will resume the sale of infusion pumps from its troubled Costa Rica facility following the lifting of a US FDA import alert.

Oil slump good for API makers, until a major supplier turns off the tap says industry group

09-Jan-2015 - Falling oil prices are good news for firms that make pharmaceutical ingredients according to a European chemical industry group.

Symbiosis looks to US as pipelines and CMO exits drive injectables demand

05-Jan-2015 - Injectable-heavy drug pipelines and increased biotech funding are driving up US demand for sterile manufacturing, according to UK-based Symbiosis, which is looking to help fill the gap left by several...

Cardinal Health to manufacture Bayer cancer drug in new Indiana facility

23-Dec-2014 - Bayer HealthCare and Cardinal Health have signed a 15-year agreement for the contract manufacturing of the castration-resistant prostate cancer drug Xofigo (radium Ra 223 dichloride).  

Baxter recalls broken saline vials

22-Dec-2014 - Baxter has recalled two batches of saline injections after healthcare workers noticed parts of the vial had broken into the product.

AstraZeneca will outsource Crestor API following UK plant closure

19-Dec-2014 - The closure of an API plant in the UK will lead to opportunities for third party manufacturers, AstraZeneca has said.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...